Journal of the American Academy of Dermatology
-
J. Am. Acad. Dermatol. · Feb 2021
Occupational dermatitis to facial personal protective equipment in health care workers: A systematic review.
Prolonged wear of facial protective equipment can lead to occupational dermatoses. ⋯ This systematic review from members of the American Contact Dermatitis Society highlights cases of occupational dermatitis to facial protective equipment, including potential offending allergens. This work may help in the diagnosis and treatment of health care workers with facial occupational dermatitis.
-
J. Am. Acad. Dermatol. · Feb 2021
Risk of systemic infections in adults with atopic dermatitis: A nationwide cohort study.
Atopic dermatitis (AD) has been linked to systemic infections in adulthood, but large-scale studies are few, and potential associations are unclear. ⋯ We found an increased risk of systemic infections among adults with hospital managed AD.
-
J. Am. Acad. Dermatol. · Feb 2021
Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children.
Little is known about mucocutaneous disease in acutely ill children and adolescents with COVID-19 and multisystem inflammatory syndrome in children (MIS-C). ⋯ Mucocutaneous disease is common among children and adolescents with COVID-19 and MIS-C. Laboratory trends observed in patients with rash may prognosticate a less severe course.
-
J. Am. Acad. Dermatol. · Jan 2021
Skin biopsy and skin cancer treatment use in the Medicare population, 1993 to 2016.
Skin biopsies are increasing at a rapid rate, and some may be unnecessary. Although skin cancer incidence is rising, there is varied biopsy accuracy between dermatologists and advanced practice professionals (APPs). A comparison of Current Procedural Terminology code (American Medical Association, Chicago, IL) use for skin biopsy and skin cancer treatment over 18 years and a comparison of provider types is needed. Excess skin biopsies increase health care costs and patient morbidity. ⋯ The number of skin biopsies has risen 153% since 1993, while the number of skin cancer treatments has only increased 39%. Our data highlight the rise of biopsy use and the increase in biopsies that do not result in skin cancer diagnosis or treatment. This suggests APPs may be responsible for increasing the cost of skin cancer management by biopsying significantly more benign lesions than dermatologists.